CNS Header

Diseases of the central nervous system

Neuropsychiatric diseases are part of Boehringer Ingelheim’s research portfolio on therapies for the central nervous system (CNS). The focus is on the circuitry of the brain and the chemistry of signal transmission. We seek innovative approaches for the treatment of the symptoms of neuropsychiatric diseases.

We therefore conduct research into symptoms and into the neurobiology of the brain in connection with various psychiatric diseases like schizophrenia, Alzheimer’s disease, and depression.

Indications:

  • depression
  • Parkinson’s disease
  • secondary stroke prophylaxis